98 results
Page 4 of 5
8-K
EX-99.1
lico376h 9m
6 Aug 19
Results of Operations and Financial Condition
7:04am
8-K
EX-99.1
24r69
14 Jun 19
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSOâ„¢ (brexanolone) Injection
9:03am
8-K
EX-99.1
ad5xdpk6vob 3fu0u
2 May 19
Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
7:25am
8-K
EX-99.1
nv7nta9fty2b8wrx
19 Mar 19
Other Events
9:08pm
8-K
i0i22
19 Mar 19
Other Events
9:08pm
424B5
5xqh945w
27 Feb 19
Prospectus supplement for primary offering
8:04am
424B5
bhy2zfs umek
25 Feb 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
c3z05lg
19 Feb 19
Sage Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress
7:07am
8-K
EX-99.1
vi0hz36xw zz6
23 Jan 19
Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors
5:03pm
8-K
EX-99.3
wbzy29yv92l
7 Jan 19
Regulation FD Disclosure
7:30am
8-K
epx5 dqvrf6
7 Jan 19
Regulation FD Disclosure
7:30am
8-K
EX-99.1
5k8n8rjl
7 Jan 19
Regulation FD Disclosure
7:30am
8-K
EX-99.1
whrnqdamp6i8mbytj70
20 Nov 18
Sage Therapeutics Receives Notification of PDUFA Extension
4:06pm
8-K
EX-99.1
iz2ea9r
6 Nov 18
Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
EX-99.1
intey
2 Nov 18
Other Events
5:26pm